GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Omid Holdings Inc (OTCPK:OMID) » Definitions » Net Income (Continuing Operations)

Omid Holdings (Omid Holdings) Net Income (Continuing Operations) : $0.00 Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Omid Holdings Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Omid Holdings's Net Income (Continuing Operations) for the three months ended in . 20 was $0.00 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.


Omid Holdings Net Income (Continuing Operations) Historical Data

The historical data trend for Omid Holdings's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omid Holdings Net Income (Continuing Operations) Chart

Omid Holdings Annual Data
Trend
Net Income (Continuing Operations)

Omid Holdings Quarterly Data
Net Income (Continuing Operations)

Omid Holdings Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omid Holdings  (OTCPK:OMID) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Omid Holdings Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Omid Holdings's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Omid Holdings (Omid Holdings) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865
Omid Holdings Inc is a health and wellness company. It is specialized in the sale and manufacture of CBD-based products. The company manufactures and sells branded inhalable, sublingual, and topical hemp-derived consumer goods. Its brands include Naturally Peaked Health, Shangri-La Life, and Peac Wellness. The company also offers design, development, manufacturing services to clients in the CBD-based cannabis industry.

Omid Holdings (Omid Holdings) Headlines

From GuruFocus

OMID Holdings Completes Share Cancellation

By PRNewswire PRNewswire 01-27-2021

OMID Announces Reduction of Common Shares

By PRNewswire PRNewswire 06-24-2021

OMID Launches New Products and Marketing

By PRNewswire PRNewswire 06-16-2020

OMID Posts Third Quarter Financial Statements

By PRNewswire PRNewswire 11-09-2021

OMID Holdings, Inc. Issues a Letter to Shareholders

By PRNewswire PRNewswire 02-26-2020

AV1 Group, Inc. Announces LOI

By Marketwired Marketwired 05-08-2019

OMID Provides Fourth-Quarter Financial Highlights

By PRNewswire PRNewswire 01-14-2021

OMID Provides Third-Quarter Financial Highlights

By PRNewswire PRNewswire 10-12-2021

OMID Makes Strategic Investment Into Psychedelic Medicine

By PRNewswire PRNewswire 08-12-2021